Chie Tatsumi

825 total citations
16 papers, 677 citations indexed

About

Chie Tatsumi is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Chie Tatsumi has authored 16 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 11 papers in Epidemiology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Chie Tatsumi's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Liver Disease and Transplantation (2 papers). Chie Tatsumi is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Liver Disease and Transplantation (2 papers). Chie Tatsumi collaborates with scholars based in Japan and China. Chie Tatsumi's co-authors include Tatsuo Inoue, Satoshi Kitai, Masatoshi Kudo, Kazuomi Ueshima, Yasunori Minami, Hobyung Chung, Taisuke Ueda, Satoru Hagiwara, Emi Ishikawa and Kiyoshi Maekawa and has published in prestigious journals such as Gastroenterology, Cytokine and Oncology.

In The Last Decade

Chie Tatsumi

16 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chie Tatsumi Japan 13 534 390 127 123 83 16 677
Carmine Coppola Italy 16 466 0.9× 359 0.9× 140 1.1× 65 0.5× 27 0.3× 32 617
Hiroyuki Takabatake Japan 10 452 0.8× 407 1.0× 157 1.2× 53 0.4× 28 0.3× 38 599
Hitoshi Tochio Japan 10 352 0.7× 198 0.5× 113 0.9× 131 1.1× 19 0.2× 26 466
Joon Koo Han South Korea 10 401 0.8× 169 0.4× 194 1.5× 131 1.1× 59 0.7× 13 718
Simona Cosconea France 4 215 0.4× 213 0.5× 125 1.0× 118 1.0× 60 0.7× 8 569
Yoshiyasu Kisaka Japan 13 445 0.8× 382 1.0× 146 1.1× 63 0.5× 17 0.2× 24 552
A Todo Japan 11 351 0.7× 187 0.5× 132 1.0× 136 1.1× 22 0.3× 24 514
Claire Castain France 7 185 0.3× 247 0.6× 92 0.7× 70 0.6× 27 0.3× 20 446
Seung Hoon Kim South Korea 11 293 0.5× 194 0.5× 116 0.9× 125 1.0× 15 0.2× 20 484
M Hirasa Japan 8 281 0.5× 152 0.4× 78 0.6× 122 1.0× 24 0.3× 27 403

Countries citing papers authored by Chie Tatsumi

Since Specialization
Citations

This map shows the geographic impact of Chie Tatsumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Tatsumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Tatsumi more than expected).

Fields of papers citing papers by Chie Tatsumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chie Tatsumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Tatsumi. The network helps show where Chie Tatsumi may publish in the future.

Co-authorship network of co-authors of Chie Tatsumi

This figure shows the co-authorship network connecting the top 25 collaborators of Chie Tatsumi. A scholar is included among the top collaborators of Chie Tatsumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chie Tatsumi. Chie Tatsumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ueshima, Kazuomi, Masatoshi Kudo, Masahiro Takita, et al.. (2011). Des-γ-Carboxyprothrombin May Be a Promising Biomarker to Determine the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma. Digestive Diseases. 29(3). 321–325. 44 indexed citations
2.
Yada, Norihisa, Masatoshi Kudo, Hobyung Chung, et al.. (2010). PEG-IFNα/RBV Combination Therapy for Chronic Hepatitis C Patients Increases Serum Ferritin Level while It Improves Sustained Viral Response Rate. Intervirology. 53(1). 60–65. 6 indexed citations
3.
Hatanaka, Kinuyo, Hobyung Chung, Masatoshi Kudo, et al.. (2010). Usefulness of the Post-Vascular Phase of Contrast-Enhanced Ultrasonography with Sonazoid in the Evaluation of Gross Types of Hepatocellular Carcinoma. Oncology. 78(Suppl. 1). 53–59. 28 indexed citations
4.
Ueda, Taisuke, Hobyung Chung, Masatoshi Kudo, et al.. (2010). Prolonged PEG-IFN and RBV Is Effective in Patients with HCV Genotype 1 and High Viral Load Who Achieved Virological Response Later than 24 Weeks. Intervirology. 53(1). 55–59. 3 indexed citations
5.
Inoue, Tatsuo, Yasunori Minami, Hobyung Chung, et al.. (2010). Radiofrequency Ablation for Hepatocellular Carcinoma: Assistant Techniques for Difficult Cases. Oncology. 78(Suppl. 1). 94–101. 21 indexed citations
6.
Ueshima, Kazuomi, Masatoshi Kudo, Masahiro Takita, et al.. (2010). Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma. Oncology. 78(Suppl. 1). 148–153. 76 indexed citations
7.
Tatsumi, Chie, Masatoshi Kudo, Kazuomi Ueshima, et al.. (2010). Non-Invasive Evaluation of Hepatic Fibrosis for Type C Chronic Hepatitis. Intervirology. 53(1). 76–81. 69 indexed citations
8.
Fujimoto, Kenji, Chie Tatsumi, Kazuomi Ueshima, et al.. (2009). M1774 Evaluation of Liver Fibrosis in Diffuse Liver Disease Using Real-Time Tissue Elastography. Gastroenterology. 136(5). A–835. 1 indexed citations
9.
Hatanaka, Kinuyo, Masatoshi Kudo, Yasunori Minami, et al.. (2008). Differential Diagnosis of Hepatic Tumors: Value of Contrast-Enhanced Harmonic Sonography Using the Newly Developed Contrast Agent, Sonazoid. Intervirology. 51(Suppl. 1). 61–69. 122 indexed citations
10.
Tatsumi, Chie, Masatoshi Kudo, Kazuomi Ueshima, et al.. (2008). Noninvasive Evaluation of Hepatic Fibrosis Using Serum Fibrotic Markers, Transient Elastography (FibroScan) and Real-Time Tissue Elastography. Intervirology. 51(Suppl. 1). 27–33. 96 indexed citations
11.
Ueshima, Kazuomi, Masatoshi Kudo, Tomoyuki Nagai, et al.. (2008). Combination Therapy with S-1 and Pegylated Interferon Alpha for Advanced Hepatocellular Carcinoma. Oncology. 75(Suppl. 1). 106–113. 15 indexed citations
12.
Xia, Yu, Masatoshi Kudo, Yasunori Minami, et al.. (2008). Response Evaluation of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas: The Usefulness of Sonazoid-Enhanced Harmonic Sonography. Oncology. 75(Suppl. 1). 99–105. 54 indexed citations
13.
Takahashi, Shunsuke, Masatoshi Kudo, Hobyung Chung, et al.. (2008). PIVKA-II Is the Best Prognostic Predictor in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation Therapy. Oncology. 75(Suppl. 1). 91–98. 24 indexed citations
14.
Takahashi, Shunsuke, Masatoshi Kudo, Hobyung Chung, et al.. (2007). Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy. Oncology. 72(Suppl. 1). 98–103. 74 indexed citations
15.
Takahashi, Shunsuke, Masatoshi Kudo, Hobyung Chung, et al.. (2007). Outcomes of Nontransplant Potentially Curative Therapy for Early-Stage Hepatocellular Carcinoma in Child-Pugh Stage A Cirrhosis Is Comparable with Liver Transplantation. Digestive Diseases. 25(4). 303–309. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026